204 related articles for article (PubMed ID: 29282139)
21. Creation, evolution, and future challenges of ion beam therapy from a medical physicist's viewpoint (Part 2). Chapter 2. Biophysical model, treatment planning system and image guided radiotherapy.
Endo M
Radiol Phys Technol; 2023 Jun; 16(2):137-159. PubMed ID: 37129777
[TBL] [Abstract][Full Text] [Related]
22. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
Gillmann C; Jäkel O; Karger CP
Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
[TBL] [Abstract][Full Text] [Related]
23. The RBE in ion beam radiotherapy: In vivo studies and clinical application.
Karger CP; Glowa C; Peschke P; Kraft-Weyrather W
Z Med Phys; 2021 May; 31(2):105-121. PubMed ID: 33568337
[TBL] [Abstract][Full Text] [Related]
24. Modeling secondary cancer risk ratios for proton versus carbon ion beam therapy: A comparative study based on the local effect model.
Hufnagl A; Johansson G; Siegbahn A; Durante M; Friedrich T; Scholz M
Med Phys; 2022 Aug; 49(8):5589-5603. PubMed ID: 35717591
[TBL] [Abstract][Full Text] [Related]
25. Dose-response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect?
Gillmann C; Lomax AJ; Weber DC; Jäkel O; Karger CP
Radiother Oncol; 2018 Jul; 128(1):109-114. PubMed ID: 29459152
[TBL] [Abstract][Full Text] [Related]
26. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous optimization of RBE-weighted dose and nanometric ionization distributions in treatment planning with carbon ions.
Burigo LN; Ramos-Méndez J; Bangert M; Schulte RW; Faddegon B
Phys Med Biol; 2019 Jan; 64(1):015015. PubMed ID: 30523890
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
29. Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
Knäusl B; Fuchs H; Dieckmann K; Georg D
Acta Oncol; 2016 Jun; 55(6):751-9. PubMed ID: 26750803
[TBL] [Abstract][Full Text] [Related]
30. Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion.
Fuchs H; Alber M; Schreiner T; Georg D
Med Phys; 2015 Sep; 42(9):5157-66. PubMed ID: 26328967
[TBL] [Abstract][Full Text] [Related]
31. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines.
El Shafie RA; Habermehl D; Rieken S; Mairani A; Orschiedt L; Brons S; Haberer T; Weber KJ; Debus J; Combs SE
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i113-9. PubMed ID: 23824114
[TBL] [Abstract][Full Text] [Related]
33. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra.
Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998
[TBL] [Abstract][Full Text] [Related]
34. RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes.
Molinelli S; Bonora M; Magro G; Casale S; Dale JE; Fossati P; Hasegawa A; Mirandola A; Ronchi S; Russo S; Preda L; Valvo F; Orecchia R; Ciocca M; Vischioni B
Radiother Oncol; 2019 Dec; 141():227-233. PubMed ID: 31522881
[TBL] [Abstract][Full Text] [Related]
35. Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer.
Haefner MF; Sterzing F; Krug D; Koerber SA; Jaekel O; Debus J; Haertig MM
Radiat Oncol; 2016 Nov; 11(1):150. PubMed ID: 27846916
[TBL] [Abstract][Full Text] [Related]
36. Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
Mein S; Kopp B; Tessonnier T; Liermann J; Abdollahi A; Debus J; Haberer T; Mairani A
Med Phys; 2022 Sep; 49(9):6082-6097. PubMed ID: 35717613
[TBL] [Abstract][Full Text] [Related]
37. Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs.
Mori S; Inaniwa T; Furukawa T; Takahashi W; Nakajima M; Shirai T; Noda K; Yasuda S; Yamamoto N
J Radiat Res; 2014 Sep; 55(5):948-58. PubMed ID: 24835238
[TBL] [Abstract][Full Text] [Related]
38. Technical note: Impact of beamline-specific particle energy spectra on clinical plans in carbon ion beam therapy.
Resch AF; Schafasand M; Lackner N; Niessen T; Beck S; Elia A; Boersma D; Grevillot L; Fossati P; Glimelius L; Stock M; Georg D; Carlino A
Med Phys; 2022 Jun; 49(6):4092-4098. PubMed ID: 35416302
[TBL] [Abstract][Full Text] [Related]
39. The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer.
Molinelli S; Vai A; Russo S; Loap P; Meschini G; Paganelli C; Barcellini A; Vitolo V; Orlandi E; Ciocca M
Radiother Oncol; 2022 Nov; 176():1-8. PubMed ID: 36113776
[TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
